Skip to main content

Strong Stewart W's Form 4 filing

Haemonetics Corp (HAE) · filed May 21, 2024

Accession no.
0001127602-24-016175
Filed
May 21, 2024
Trade date
May 17-20, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $65.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Strong Stewart WCIK 0001420910Officer (President, Global Hospital)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 17, 2024Common StockFTax withholdingDisposed−284$95.73−$27,187.3215,324Direct
May 17, 2024Common StockAGrant or awardAcquired+2,872––18,196Direct
May 20, 2024Common StockMOption exerciseAcquired+2,241$56.57+$126,773.3720,437Direct
May 20, 2024Common StockFTax withholdingDisposed−1,555$95.08−$147,849.418,882Direct
May 20, 2024Common StockSSaleDisposed−686$95.11−$65,245.4618,196Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 17, 2024Common StockAGrant or awardAcquired+6,313$0.00$06,313Direct
May 20, 2024Common StockMOption exerciseDisposed−2,241$0.00$02,242Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)